These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1849518)

  • 1. Ki-67 staining in histological subtypes of breast carcinoma and fine needle aspiration smears.
    Kuenen-Boumeester V; Van Der Kwast TH; Van Laarhoven HA; Henzen-Logmans SC
    J Clin Pathol; 1991 Mar; 44(3):208-10. PubMed ID: 1849518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit.
    Kommoss F; Colley M; Hart CE; Franklin WA
    Mol Cell Probes; 1990 Feb; 4(1):11-23. PubMed ID: 1969111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring proliferation in routine fine needle aspirates. Immunocytochemical detection of bromodeoxyuridine incorporation and Ki-67 expression in breast aspirates.
    Buley ID; Morrison EH; Kaklamanis L; Horak E; Gatter KC
    Cytopathology; 1992; 3(3):149-54. PubMed ID: 1511119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas.
    Ellis PA; Makris A; Burton SA; Titley J; Ormerod MG; Salter J; Powles TJ; Smith IE; Dowsett M
    Br J Cancer; 1996 Mar; 73(5):640-3. PubMed ID: 8605100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.
    Tuccari G; Rizzo A; Muscarà M; Giuffrè G; Barresi G
    Pathologica; 1993; 85(1095):47-55. PubMed ID: 8100059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative activity (Ki-67), WT p53, Bcl-2 expression and their relationship to the tumor grade, in invasive ductal breast carcinomas.
    Kalogeraki A; Garbagnati F; Santinami M; Zoras O
    In Vivo; 2002; 16(2):141-4. PubMed ID: 12073773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
    Markiewski M; Domagała W
    Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleolar organizer regions and Ki-67 immunostaining in ductal breast cancer: a comparative study.
    Canepa M; Gambini C; Sementa AR; Borgiani L; Rovida S
    Pathologica; 1990; 82(1078):125-32. PubMed ID: 2168032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and distribution in normal and tumoral human tissues of breast cancer-associated antigen defined by monoclonal antibody 7B10.
    Pancino GF; Le Doussal V; Mortada MH; Berthon P; Osinaga E; Calvo F; Roseto A
    Cancer Res; 1989 Dec; 49(24 Pt 1):7078-85. PubMed ID: 2555058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical staining of proliferating cells in fine needle aspiration smears of primary and metastatic breast tumours.
    Kuenen-Boumeester V; Blonk DI; Van der Kwast TH
    Br J Cancer; 1988 May; 57(5):509-11. PubMed ID: 3395556
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison between Ki-67 antibody reactivity and other pathological variables in breast carcinoma.
    Bilous AM; McKay M; Milliken J
    Pathology; 1991 Oct; 23(4):282-5. PubMed ID: 1664511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation index in various stages of breast cancer determined by Ki-67 immunostaining.
    Pence JC; Kizilbash AM; Kerns BJ; Marks JR; Iglehart JD
    J Surg Oncol; 1991 Sep; 48(1):11-20. PubMed ID: 1716331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
    Narita T; Funahashi H; Satoh Y; Takagi H
    Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between Ki-67 index and S-phase fraction on fine-needle aspiration samples from breast carcinoma.
    Bozzetti C; Nizzoli R; Camisa R; Guazzi A; Ceci G; Cocconi G; Mazzini G; Naldi N
    Cancer; 1997 Oct; 81(5):287-92. PubMed ID: 9349516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of surface antigens defined by monoclonal antibodies in primary mucinous breast carcinomas. Relation to prognostic factors and recurrence-free survival.
    Rasmussen BB; Rose C; Hilkens J; Hilgers J
    Virchows Arch A Pathol Anat Histopathol; 1986; 409(4):497-505. PubMed ID: 3016978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cancer histology on the success of fine needle aspiration of the breast.
    Lamb J; Anderson TJ
    J Clin Pathol; 1989 Jul; 42(7):733-5. PubMed ID: 2547846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytologic presentation of mammary carcinoma on aspiration biopsy smears.
    Wallgren A; Zajicek J
    Acta Cytol; 1976; 20(5):469-78. PubMed ID: 185869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
    Naidu R; Wahab NA; Yadav MM; Kutty MK
    Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables.
    Frierson HF
    Mod Pathol; 1993 May; 6(3):290-4. PubMed ID: 8102204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the tumour-associated antigen TAG-12 by monoclonal antibody 7A9 in normal, benign and malignant mammary tissues.
    Werner M; von Wasielewski R; Bernhards J; Georgii A
    Virchows Arch A Pathol Anat Histopathol; 1990; 416(5):411-6. PubMed ID: 2156377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.